Benzinga
@Benzinga
Financial News, Data & Education 💸
加入 June 2009
850 正在关注 343.9K 粉丝
Revolution Medicines ($RVMD) won FDA approval for Rasonque, a first-of-its-kind targeted pancreatic cancer drug.
In Phase 3, the treatment cut death risk by 60% and nearly doubled median overall survival versus chemotherapy.
显示更多
